Literature DB >> 3523246

Hyperinsulinemia in a population at high risk for non-insulin-dependent diabetes mellitus.

S M Haffner, M P Stern, H P Hazuda, J A Pugh, J K Patterson.   

Abstract

The prevalence of non-insulin-dependent diabetes mellitus (NIDDM) is higher in Mexican Americans than in non-Hispanic white Americans, even after adjustment for the former's greater overall and more centralized adiposity. We postulated that this excess risk of NIDDM could be due to resistance to insulin. We performed oral glucose-tolerance tests with measurements of serum insulin concentrations in 225 Mexican Americans and 180 non-Hispanic whites without diabetes as part of the San Antonio Heart Study, a population-based study of risk factors for diabetes. Changes in serum insulin concentrations in response to the glucose challenge were quantified by the area under the serum insulin curve. Overall adiposity was characterized by body-mass index, and regional body-fat distribution by the ratio of subscapular to triceps skinfolds and the ratio of waist to hip circumference. After adjustment for these indicators of adiposity and also for differences in glucose tolerance, Mexican Americans were found to have significantly greater areas under the serum insulin curve than non-Hispanic whites. These data suggest that, like other populations at high risk for NIDDM such as Pima Indians and Micronesians, Mexican Americans have more hyperinsulinemia than can be accounted for by their adiposity.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3523246     DOI: 10.1056/NEJM198607243150403

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  55 in total

1.  Type 2 diabetes is prevalent and poorly controlled among Hispanic elders of Caribbean origin.

Authors:  K L Tucker; O I Bermudez; C Castaneda
Journal:  Am J Public Health       Date:  2000-08       Impact factor: 9.308

2.  Cardiovascular risk factors in Mexican American adults: a transcultural analysis of NHANES III, 1988-1994.

Authors:  J Sundquist; M A Winkleby
Journal:  Am J Public Health       Date:  1999-05       Impact factor: 9.308

3.  Pathophysiological role of enhanced bone marrow adipogenesis in diabetic complications.

Authors:  Meghan A Piccinin; Zia A Khan
Journal:  Adipocyte       Date:  2014-12-10       Impact factor: 4.534

4.  Screening for insulin receptor gene DNA polymorphisms associated with glucose intolerance in a Scandinavian population.

Authors:  M Sten-Linder; S Vilhelmsdotter; A Wedell; I Stern; T Pollare; P Arner; S Efendić; R Luft; H Luthman
Journal:  Diabetologia       Date:  1991-04       Impact factor: 10.122

5.  Genetic and environmental architecture of the features of the insulin-resistance syndrome.

Authors:  Y Hong; N L Pedersen; K Brismar; U de Faire
Journal:  Am J Hum Genet       Date:  1997-01       Impact factor: 11.025

6.  Therapeutic efficacy of umbilical cord-derived mesenchymal stem cells in patients with type 2 diabetes.

Authors:  Li-Xue Guan; Hui Guan; Hai-Bo Li; Cui-Ai Ren; Lin Liu; Jin-Jin Chu; Long-Jun Dai
Journal:  Exp Ther Med       Date:  2015-03-09       Impact factor: 2.447

7.  Insulin resistance in relatives of NIDDM patients: the role of physical fitness and muscle metabolism.

Authors:  B Nyholm; A Mengel; S Nielsen; C Skjaerbaek; N Møller; K G Alberti; O Schmitz
Journal:  Diabetologia       Date:  1996-07       Impact factor: 10.122

8.  Three-year prospective evaluation of glucose tolerance, beta-cell function and peripheral insulin sensitivity in non-diabetic patients with thalassemia major.

Authors:  M F Messina; F Lombardo; A Meo; M Miceli; M Wasniewska; M Valenzise; C Ruggeri; T Arrigo; F De Luca
Journal:  J Endocrinol Invest       Date:  2002-06       Impact factor: 4.256

9.  Growth hormone treatment in children with preterminal chronic renal failure: no adverse effect on glomerular filtration rate.

Authors:  B Tönshoff; C Tönshoff; O Mehls; J Pinkowski; W F Blum; U Heinrich; B Stöver; N Gretz
Journal:  Eur J Pediatr       Date:  1992-08       Impact factor: 3.183

10.  Hyperinsulinaemia: the key feature of a cardiovascular and metabolic syndrome.

Authors:  E Ferrannini; S M Haffner; B D Mitchell; M P Stern
Journal:  Diabetologia       Date:  1991-06       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.